Publications by authors named "Atham Ali"

Claim this Profile
E
Enhanced T cell activation and cytotoxicity against AML via targeted anti-CD99 nanoparticle treatment.
Shephali Kadam, Atham Ali, Mateusz Pospiech, Sandra Onyemaechi, Yiting Meng

Biomed Pharmacother· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLT3/CD99 Bispecific Antibody-Based Nanoparticles for Acute Myeloid Leukemia.
Atham Ali, Alvin Phan, Vijaya Vaikari, Mincheol Park, Mateusz Pospiech

Cancer Res Commun· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
αB-Crystallin Peptide Fused with Elastin-like Polypeptide: Intracellular Activity in Retinal Pigment Epithelial Cells Challenged with Oxidative Stress.
Sara Aly Attia, Anh Tan Truong, Alvin Phan, Shin-Jae Lee, Manal Abanmai, Atham Ali

Antioxidants (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deletion of CD36 exhibits limited impact on normal hematopoiesis and the leukemia microenvironment.
Yiting Meng, Mateusz Pospiech, Atham Ali, Ritu Chandwani, Mary Vergel

Cell Mol Biol Lett· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD99 in malignant hematopoiesis.
Atham Ali, Vijaya Pooja Vaikari, Houda Alachkar

Exp Hematol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies targeting FLT3 beyond the kinase inhibitors.
Mohammed F Almatani, Atham Ali, Sandra Onyemaechi, Yang Zhao, Lucas Gutierrez

Pharmacol Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis